… Walsh, and J. Symes. 1996. Clinical evidence of angiogenesis following arterial gene …
Keyt, JM Isner, and JF Symes. 1996. VEGF improves myocardial blood flow but produces EDRF-…

… Carpenter, and JF Symes. A persistent hind limb ischemia model in the rabbit. J. Invest.
Surg… J. Wright. The effect of long-term vasodilation on capillary growth and performenace in …

… James F Symes … testing of the plasmid, Kathleen Hogan, Dave Cave, and Jay Duker for
evaluating the patient's suitability for arterial gene therapy, and Susan Kelly, patient's advocate. …

Background—We initiated a phase 1 clinical study to determine the safety and bioactivity of
direct myocardial gene transfer of vascular endothelial growth factor (VEGF) as sole therapy …

Background Recent studies have suggested that vascular endothelial growth factor (VEGF)
and basic fibroblast growth factor (bFGF) may have synergistic effects on the induction of …

Objective To assess the reliability and validity of the Southampton mindfulness questionnaire
(SMQ), a 16‐item measure of mindful awareness of distressing thoughts and images. …

Background Most strategies designed to reduce restenosis by the use of pharmacological
or biological reagents involve direct inhibition of vascular smooth muscle cell (SMC) …

… Dr Symes and his colleagues ought to be congratulated on being in the forefront in studying
this important and promising molecule … I have the following questions for Dr Symes. …

Rationale: Although accumulating data support the efficacy of intramyocardial cell-based
therapy to improve left ventricular (LV) function in patients with chronic ischemic …

Background Striated muscle has been shown to be capable of taking up and expressing
foreign genes transferred in the form of naked plasmid DNA, although typically with a low level …